Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

Summary

The purpose of this migraine prevention study is to evaluate the efficacy and safety of AST-726 in moderate to severe migraine patients at one of two doses compared to placebo and compared to a baseline period as measured by a reduction in the number of migraine days.

Timeline

Start

2007-05

Primary completion

2008-06

Completion

2008-06

Drugs

Indications